The Blue Cross and Blue Shield Association sponsored a 400-page report released in
October 2002 that concluded that 19% of the increase in hospital costs between 1998 and …

Objective To examine variation in pharmaceutical spending and patient characteristics
across prescription drug user groups. Data Sources British Columbia's population‐based …

Importance In OECD countries, pharmaceutical spending reached around 800 billion USD
in 2013, accounting for about 20% of total spending in the retail sector. Pharmaceutical …

In appropriate prescribing is a global problem. It is especially salient in China, where drug
sales constitute a major portion of health care providers' incomes, price distortions are …

The prescribing behavior to prescribe high-priced drugs has been hypothesized to be
related to the increasing drug expenditures in China, but little empirical evidence exists. The …

In 1980, drug consumption per capita was 455 Swedish crowns (SEK) in Sweden, SEK 452
in Denmark, SEK 384 in Finland and SEK 382 in Norway; actual figures for Denmark …

Background The cost of pharmaceuticals has increased rapidly in Korea in recent years.
Expenditure is likely to grow further with the policy of expanding National Health Insurance …

The questions asked in this thesis relate to the economic incentives and characteristics of
the health care market, which may result in suboptimal drug prescription. We consider two …

Background Variation in prescription costs between general practices and within practices
over time is poorly understood. Methods From New Zealand's national health data …